Lok Him Yu is a prominent inventor based in Sacramento, California, known for his significant contributions to pharmaceutical research and development. He holds two patents that exhibit his innovative approach towards drug formulation and synthesis.

Latest Patents

His latest patents focus on the solid forms of an ASK1 inhibitor, specifically the crystalline forms of the compound 5-(4-cyclopropyl-1H-imidazol-1-yl)-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-2-fluoro-4-methylbenzamide (Compound I). These formulations have been meticulously prepared and characterized in the solid state, providing valuable insights into both the processes of manufacture and the methods of utilizing these crystalline forms for therapeutic applications.

Career Highlights

Lok Him Yu currently works at Gilead Sciences, Inc., a leading biopharmaceutical company. His work at Gilead showcases his dedication to advancing healthcare solutions through innovative drug discovery and development.

Collaborations

Throughout his career, Lok has collaborated with several accomplished professionals in the field, including Mark Andres and Brenda J Burke Chan. These partnerships have bolstered the research efforts and contributed to the successful outcomes of their innovative projects.

Conclusion

Lok Him Yu stands out as an influential inventor in the realm of pharmaceutical innovations. His patents not only reflect his expertise but also signify his commitment to enhancing therapeutic options available in the market. As he continues to collaborate with other leading experts, Lok is poised to make further contributions that can significantly benefit the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.